rs1043505718

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6

The NM_001407446.1(APC):​c.16G>A​(p.Gly6Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000686 in 1,370,660 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/15 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G6A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00030 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000040 ( 0 hom. )

Consequence

APC
NM_001407446.1 missense

Scores

14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: -0.302

Publications

9 publications found
Variant links:
Genes affected
APC (HGNC:583): (APC regulator of WNT signaling pathway) This gene encodes a tumor suppressor protein that acts as an antagonist of the Wnt signaling pathway. It is also involved in other processes including cell migration and adhesion, transcriptional activation, and apoptosis. Defects in this gene cause familial adenomatous polyposis (FAP), an autosomal dominant pre-malignant disease that usually progresses to malignancy. Mutations in the APC gene have been found to occur in most colorectal cancers, where disease-associated mutations tend to be clustered in a small region designated the mutation cluster region (MCR) and result in a truncated protein product. [provided by RefSeq, Jun 2022]
APC Gene-Disease associations (from GenCC):
  • classic or attenuated familial adenomatous polyposis
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • desmoid tumor
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp
  • familial adenomatous polyposis 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • gastric adenocarcinoma and proximal polyposis of the stomach
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen, Orphanet
  • sarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • APC-related attenuated familial adenomatous polyposis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Turcot syndrome with polyposis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Cenani-Lenz syndactyly syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.023428679).
BP6
Variant 5-112707733-G-A is Benign according to our data. Variant chr5-112707733-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 469801.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
APCNM_001407446.1 linkc.16G>A p.Gly6Ser missense_variant Exon 1 of 16 NP_001394375.1
APCNM_001354897.2 linkc.16G>A p.Gly6Ser missense_variant Exon 1 of 15 NP_001341826.1
APCNM_001127511.3 linkc.16G>A p.Gly6Ser missense_variant Exon 1 of 14 NP_001120983.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
APCENST00000507379.6 linkc.16G>A p.Gly6Ser missense_variant Exon 1 of 14 2 ENSP00000423224.2
APCENST00000505350.2 linkn.16G>A non_coding_transcript_exon_variant Exon 1 of 16 3 ENSP00000481752.1
APCENST00000713636.1 linkn.-168G>A non_coding_transcript_exon_variant Exon 1 of 17 ENSP00000518937.1

Frequencies

GnomAD3 genomes
AF:
0.000296
AC:
45
AN:
152162
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00104
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000953
AC:
13
AN:
136392
AF XY:
0.0000809
show subpopulations
Gnomad AFR exome
AF:
0.00202
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000402
AC:
49
AN:
1218380
Hom.:
0
Cov.:
31
AF XY:
0.0000302
AC XY:
18
AN XY:
595232
show subpopulations
African (AFR)
AF:
0.00155
AC:
44
AN:
28304
American (AMR)
AF:
0.0000325
AC:
1
AN:
30764
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
21058
East Asian (EAS)
AF:
0.00
AC:
0
AN:
24240
South Asian (SAS)
AF:
0.00
AC:
0
AN:
76906
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
13134
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4894
European-Non Finnish (NFE)
AF:
0.00000206
AC:
2
AN:
970788
Other (OTH)
AF:
0.0000414
AC:
2
AN:
48292
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
3
7
10
14
17
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000296
AC:
45
AN:
152280
Hom.:
0
Cov.:
32
AF XY:
0.000309
AC XY:
23
AN XY:
74456
show subpopulations
African (AFR)
AF:
0.00103
AC:
43
AN:
41554
American (AMR)
AF:
0.000131
AC:
2
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68014
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.000306

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1
Jul 20, 2017
PreventionGenetics, part of Exact Sciences
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Familial adenomatous polyposis 1 Benign:1
Jan 26, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.22
T
BayesDel_noAF
Benign
-0.10
CADD
Benign
13
DANN
Benign
0.94
Eigen
Benign
-0.75
Eigen_PC
Benign
-0.79
FATHMM_MKL
Benign
0.062
N
LIST_S2
Benign
0.56
T
MetaRNN
Benign
0.023
T
MetaSVM
Benign
-0.56
T
PhyloP100
-0.30
PROVEAN
Benign
-0.070
N
REVEL
Benign
0.27
Sift
Benign
0.41
T
MutPred
0.13
Gain of glycosylation at G6 (P = 0.0225);
MVP
0.76
ClinPred
0.043
T
GERP RS
-0.12
PromoterAI
-0.021
Neutral
Mutation Taster
=296/4
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1043505718; hg19: chr5-112043430; API